210 related articles for article (PubMed ID: 2416370)
21. Determination of estrogen and progesterone receptors in endometrial adenocarcinomas. Comparison between dextran-coated charcoal and immunoenzymatic methods on curettage biopsies.
Marchal S; Marchal C; Hoffstetter S; Parache RM; Pernot M
Anticancer Res; 1992; 12(4):1307-10. PubMed ID: 1380228
[TBL] [Abstract][Full Text] [Related]
22. [Comparative study of estrogen receptor assays between immunocytochemical assay using monoclonal antibody and the dextran- coated charcoal method].
Toi M; Hamada Y; Seto Y; Hisamatsu K; Suehiro S; Toge T; Niimoto M; Hattori T
Gan To Kagaku Ryoho; 1986 Oct; 13(10):3056-62. PubMed ID: 2429620
[TBL] [Abstract][Full Text] [Related]
23. Determination of estrogen receptor in breast cancer using monoclonal antibody technology: results of a multicenter study in the United States.
Jordan VC; Jacobson HI; Keenan EJ
Cancer Res; 1986 Aug; 46(8 Suppl):4237s-4240s. PubMed ID: 3524804
[TBL] [Abstract][Full Text] [Related]
24. Estrogen and progesterone receptors in breast cancer: comparison between enzyme immunoassay and computer-assisted image analysis of immunocytochemical assay.
Cavaliere A; Bucciarelli E; Sidoni A; Bianchi G; Pietropaoli N; Ludovini V; Vitali R
Cytometry; 1996 Sep; 26(3):204-8. PubMed ID: 8889392
[TBL] [Abstract][Full Text] [Related]
25. Determination of estrogen receptors in human breast cancer: comparison between enzyme immunoassay and dextran-coated charcoal method.
Bozzetti C; Naldi N; Guazzi A; Nizzoli R; Benecchi M; Cocconi G
Tumori; 1986 Oct; 72(5):511-4. PubMed ID: 2432712
[TBL] [Abstract][Full Text] [Related]
26. An enzyme immunoassay compared with a ligand-binding assay for measuring progesterone receptors in cytosols from breast cancers.
Smyth CM; Benn DE; Reeve TS
Clin Chem; 1988 Jun; 34(6):1116-8. PubMed ID: 3288376
[TBL] [Abstract][Full Text] [Related]
27. Evolution of immunoreactivity of monoclonal antibodies H222 and/or D547 used in the detection of breast cancer estrogen receptors. Varying reactivity of receptor isoforms.
Cren H; Lechevrel C; Roussel G; Goussard J
J Steroid Biochem Mol Biol; 1991 Oct; 39(4A):519-27. PubMed ID: 1911441
[TBL] [Abstract][Full Text] [Related]
28. Comparison of biochemical and immunoenzymatic macromethods and a new immunocytochemical micromethod for assaying estrogen receptors in human breast carcinomas.
Devleeschouwer N; Faverly D; Kiss R; Legros N; de Launoit Y; Ryckaert C; Andry M; Lenglet G; Paridaens R; Gompel CM
Acta Cytol; 1988; 32(6):816-24. PubMed ID: 2462316
[TBL] [Abstract][Full Text] [Related]
29. Whither cytosolic estrogen receptor assays? A comparison of commercially available kits for estrogen receptor assay.
Bilous AM; Tyler JP; Toppila M; Milliken J
Pathology; 1987 Jul; 19(3):223-8. PubMed ID: 3324022
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of an enzyme immunoassay kit for estrogen receptor measurements.
Raam S; Vrabel DM
Clin Chem; 1986 Aug; 32(8):1496-502. PubMed ID: 2426007
[TBL] [Abstract][Full Text] [Related]
31. Quality control requirements in estrogen receptor determination.
Bojar H
Cancer Res; 1986 Aug; 46(8 Suppl):4249s-4250s. PubMed ID: 3524806
[TBL] [Abstract][Full Text] [Related]
32. Comparison of immunocytochemical estrogen receptor assay, estrogen receptor enzyme immunoassay, and radioligand-labeled estrogen receptor assay in human breast cancer and uterine tissue.
Heubner A; Beck T; Grill HJ; Pollow K
Cancer Res; 1986 Aug; 46(8 Suppl):4291s-4295s. PubMed ID: 3524810
[TBL] [Abstract][Full Text] [Related]
33. Determination of estrogen receptors in paraffin-embedded tissue. Techniques and the value in breast cancer treatment.
Andersen J
Acta Oncol; 1992; 31(6):611-27. PubMed ID: 1281648
[TBL] [Abstract][Full Text] [Related]
34. Different clinical impact of estradiol receptor determination according to the analytical method: A study on 1940 breast cancer patients over a period of 16 consecutive years.
Magné N; Toillon RA; Castadot P; Ramaioli A; Namer M
Breast Cancer Res Treat; 2006 Jan; 95(2):179-84. PubMed ID: 16317583
[TBL] [Abstract][Full Text] [Related]
35. Steroid receptors in breast cancer: sources of inter-laboratory variation in dextran-charcoal assays.
Thorpe SM
Breast Cancer Res Treat; 1987; 9(3):175-89. PubMed ID: 2444291
[TBL] [Abstract][Full Text] [Related]
36. Radioligand-labeled binding assay and immunochemical assay for estrogen receptor in 115 human breast cancers.
Riccobon A; Zoli W; Capucci A; Volpi A; Vasini M; Bonaguri C; Flamini E; Ravaioli A; Amadori D
Tumori; 1988 Apr; 74(2):167-70. PubMed ID: 3285555
[TBL] [Abstract][Full Text] [Related]
37. Characterization of laboratory working standard for quality control of immunometric and radiometric estrogen receptor assays. Clinical evaluation on breast cancer biopsies. Italian Committee for Hormone Receptor Assays Standardization.
Piffanelli A; Pelizzola D; Giovannini G; Catozzi L; Faggioli L; Giganti M
Tumori; 1989 Dec; 75(6):550-6. PubMed ID: 2482565
[TBL] [Abstract][Full Text] [Related]
38. Detection of different estrogen receptor forms in breast cancer cytosol by enzyme immunoassay.
Dittadi R; Meo S; Amoroso B; Gion M
Cancer Res; 1997 Mar; 57(6):1066-72. PubMed ID: 9067273
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of an enzyme immunoassay for estrogen receptors in human breast cancers.
Nicholson RI; Colin P; Francis AB; Keshra R; Finlay P; Williams M; Elston CW; Blamey RW; Griffiths K
Cancer Res; 1986 Aug; 46(8 Suppl):4299s-4302s. PubMed ID: 3524811
[TBL] [Abstract][Full Text] [Related]
40. Comparative measurement of progesterone receptors in breast cancer by biochemical and immunoenzymatic assays.
Métayé T; Bounaud JY; Begon F
Ann Biol Clin (Paris); 1990; 48(10):732-6. PubMed ID: 2082763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
